EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The potential of methioninase for cancer treatment

Louay Abo Qoura, Konstantin V Balakin, Robert M Hoffman, Vadim S Pokrovsky

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-07 · 1879 (4) · 189122

DOI: 10.1016/j.bbcan.2024.189122 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-07. Verfasst von Louay Abo Qoura und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Molecular and Cellular Medicine, People's Friendship University of Russia (RUDN University), 117198 Moscow, Russia; N.N. Blokhi…. Hauptthemen laut MEDLINE: Carbon-Sulfur Lyases, Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 160 Literaturangaben. Gefördert von: Ministry of Education and Science of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells are addicted to L-methionine (L-Met) and have a much greater requirement for L-Met than normal cells due to excess transmethylation, termed the Hoffman effect. By targeting this vulnerability through dietary restriction of L-Met, researchers have been able to achieve promising results in inhibiting tumor growth and eradicating cancer cells. Methioninase (EC 4.4.1.11; METase) catalyzes the transformation of L-Met into α-ketobutyrate, ammonia, and methanethiol. The use of METase was initially limited due to its poor stability in vivo, high immunogenicity, and enzyme-induced inactivating antibodies. These issues could be partially resolved by PEGylation, encapsulation in erythrocytes, and various site-directed mutagenesis. The big breakthrough came when it was discovered that METase is effectively administered orally. The enzyme L-asparaginase is approved by the FDA for treatment of acute lymphoblastic leukemia. METase has more potential as a therapeutic since addiction to L-Met is a general and fundamental hallmark of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon-Sulfur LyasesNeoplasmsHumansMethionineAnimalsAntineoplastic Agents

Stichwörter der Autor:innen

Hoffman effectMETase mutantsMETase-loaded erythrocytesModified METaseOral METase

Substanzen

Carbon-Sulfur LyasesL-methionine gamma-lyaseMethionineAntineoplastic Agents

Autor:innen und Institutionen

  • Research Institute of Molecular and Cellular Medicine, People's Friendship University of Russia (RUDN University), 117198 Moscow, Russia; N.N. Blokhin National Medical Research Center of Oncology of Ministry of Health o…
  • Moscow Institute of Physics and Technology, 141701 Moscow region, Russia.
  • AntiCancer Inc., San Diego, CA 92111, USA; Department of Surgery, University of California, San Diego, La Jolla, CA 92037-7400, USA.

Förderung

  • Ministry of Education and Science of the Russian Federation

Zitieren

APA

Abo Qoura, L., Balakin, K. V., Hoffman, R. M., & Pokrovsky, V. S. (2024). The potential of methioninase for cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(4), 189122. https://doi.org/10.1016/j.bbcan.2024.189122

Vancouver

Abo Qoura L, Balakin KV, Hoffman RM, Pokrovsky VS. The potential of methioninase for cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(4):189122. doi:10.1016/j.bbcan.2024.189122

BibTeX
@article{AboQoura2024,
  author = {Abo Qoura, Louay and Balakin, Konstantin V and Hoffman, Robert M and Pokrovsky, Vadim S},
  title = {The potential of methioninase for cancer treatment},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2024},
  volume = {1879},
  number = {4},
  pages = {189122},
  doi = {10.1016/j.bbcan.2024.189122}
}
Kostenlos starten →